Purchase Order 36C24826P0647
- Not listed
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 8 (VISN 8) awarded a firm fixed-price purchase order to Novocure Inc. on January 16, 2026, with a ceiling value of $49,748.73 and an ultimate completion date of March 31, 2026. This contract, classified as a van conversion, will be performed in Fresno, California and carries no set-aside designation. Novocure Inc., a foreign-owned medical device manufacturer specializing in cancer treatment technologies, serves as the...
- On February 25, 2026, the Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a delivery order to Novocure Inc. for prosthetics-novocure transducers with a ceiling value of $49,748.73 and a completion date of June 24, 2026. This firm fixed-price delivery order was issued without a set-aside designation and will be performed in Fresno, California. Novocure Inc., a foreign-owned medical device manufacturer specializing in innovative cancer treatment technologies, serves...
- The Department of Veterans Affairs Veterans Integrated Service Network 21 awarded a $49,748.73 firm fixed-price delivery order to Novocure Inc. on December 17, 2025, for the provision of Optune prosthetic cancer treatment devices. This delivery order, with an ultimate completion date of March 31, 2026, is issued under Novocure's General Services Administration Medical Equipment and Supplies Federal Supply Schedule contract (FSS-65-II-A), a $28.85 million multiple-award vehicle established in...
- Novocure Inc. was awarded a $49,748.73 firm fixed-price delivery order by Veterans Integrated Service Network (VISN) 21, under the Department of Veterans Affairs, to provide Optune Plus transducers for prosthetic applications. The delivery order, issued on January 13, 2026, will be completed by May 13, 2026, with performance at the VA facility in Fresno, California. This award was issued without a set-aside designation and represents a continuation of Novocure's established role as the prime...
- Novocure Inc. was awarded a $49,748.73 firm fixed-price delivery order by Veterans Integrated Service Network 4 (VISN 4) on March 6, 2026, for Optune Plus transducers with an ultimate completion date of September 30, 2026. The award will be performed in Coatesville, Pennsylvania, and represents a delivery order issued under Novocure's existing Medical Equipment and Supplies Federal Supply Schedule contract (FSS-65-II-A) with the Department of Veterans Affairs Veterans Health Administration. This...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 6 (VISN 6), awarded a firm fixed-price purchase order valued at $49,748.73 to Novocure Inc. for an implant product, with an ultimate completion date of March 27, 2026. The contract, which was awarded on February 27, 2026, carries no set-aside designation and will be performed in Portsmouth, New Hampshire. Novocure Inc., a foreign-owned medical device manufacturer specializing in innovative cancer treatment technologies,...
- The Department of Veterans Affairs, Veterans Integrated Service Network 10, awarded a delivery order valued at $49,748.73 to Novocure Inc. for Optune transducers on January 21, 2026, with an ultimate completion date of March 20, 2026. This firm fixed-price delivery order, which carries no set-aside designation, is issued under Novocure's General Services Administration Federal Supply Schedule contract for Medical Equipment and Supplies (FSS-65-II-A), a $28.85 million multiple-award vehicle...
- The Department of Veterans Affairs, Veterans Integrated Service Network 15 (VISN 15), awarded a $49,748.73 firm fixed-price purchase order to Novocure Inc. on October 30, 2025, for the rental of Optune Plus transducers. The contract, with an ultimate completion date of March 31, 2026, will be performed in Portsmouth, New Hampshire. Novocure Inc., a foreign-owned medical device manufacturer specializing in Tumor Treating Fields (TTFields) technology, will provide non-invasive cancer treatment...
- Novocure Inc. was awarded a $49,748.73 firm fixed-price delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 1 (VISN 1) for Optune Plus transducers, with an ultimate completion date of March 30, 2026. The award, issued on December 29, 2025, represents a non-set-aside procurement for medical devices to be delivered to Portsmouth, New Hampshire. This delivery order is issued under Novocure's existing General Services Administration Federal Supply Schedule...
- The Department of Veterans Affairs' Veterans Integrated Service Network 21 awarded a delivery order valued at approximately $49.7K to Novocure Inc. on December 19, 2025, for Optune transducers, with final completion scheduled for April 18, 2026. This firm fixed-price contract, placed under Novocure's existing Federal Supply Schedule contract for Medical Equipment and Supplies (FSS-65-II-A), requires performance in Fresno, California. No set-aside designation was utilized for this award. Novocure...
The Department of Veterans Affairs, Veterans Integrated Service Network 8 (VISN 8) awarded a $49,748.73 firm fixed-price purchase order to Novocure Inc. for van conversion services, with a completion date of March 31, 2026. The award was issued on March 25, 2026 without a set-aside designation for performance at a location in Fresno, California. This purchase order represents a delivery order under Novocure's existing Federal Supply Schedule contract (FSS-65-II-A) for Medical Equipment and Supplies, a $28.85 million multiple-award vehicle established November 1, 2022 and extending through October 31, 2027. Novocure Inc., a foreign-owned medical device manufacturer specializing in cancer treatment technologies, serves as the sole prime contractor on this award with no subcontractor involvement. The company is the primary provider of Optune Tumor Treating Fields therapy systems to VA medical centers nationwide, having issued over 100 delivery orders and purchase orders across VISNs 1 through 23. This contract supports the VA's strategic objective to expand veterans' access to innovative, non-invasive cancer treatment options across its integrated service network, with Novocure maintaining direct control and quality assurance over its proprietary medical device technologies throughout service delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.7k | 3/25/26 |